> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance on HCT/P Donor Screening to Reduce Zika Virus
- URL: https://www.fdaweb.com/guidance-on-hct-p-donor-screening-to-reduce-zika-virus/
- Published: 2016-03-07T12:00:00.000Z
- Updated: 2026-09-15T02:41:25.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134986

*Federal Register* Notice: FDA is making available a document entitled *Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products; Guidance for Industry.* It provides establishments that make donor eligibility determinations for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps) with recommendations for screening donors for evidence of, and risk factors for, infection with Zika virus (ZIKV). The guidance identifies ZIKV as a relevant communicable disease agent or disease (RCDAD) and adds to recommendations contained in the guidance entitled *Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)* dated 8/2007\. To download this guidance, click [here](http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/UCM488582.pdf?ref=fdaweb.com). To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-03-07/pdf/2016-04893.pdf?ref=fdaweb.com)